Evidence map›Paper›PMID 24237692›Full record

ArticleCell host & microbe2013

Candida albicans: adapting to succeed.

David Kadosh, Jose L Lopez-Ribot

Abstract readComment
In one paragraph

Article in Cell host & microbe, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Roles of P-body factors inbioRxiv : the preprint server for biology · 2025
    Article
  2. Article
  3. Antifungal and antibiofilm effects of probioticFrontiers in cellular and infection microbiology · 2024
    Article
  4. Changes ofIndian journal of microbiology · 2023
    Article
  5. Review
  6. A Planarian Model System to Study Host-Pathogen Interactions.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  7. Article
  8. Review
  9. Frontiers in microbiology · 2022
    Article
  10. On and Off: Epigenetic Regulation ofPathogens (Basel, Switzerland) · 2021
    Review
  11. Inhibitory Effect of Morin AgainstFrontiers in microbiology · 2020
    Article
  12. Article
  13. Article
  14. Frontiers in cellular and infection microbiology · 2018
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

David KadoshDepartment of Microbiology and Immunology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Jose L Lopez-Ribot

Funding

Targeting virulence against oral candidiasis in HIV/AIDSR01DE023510 · NIDCR · UNIVERSITY OF TEXAS SAN ANTONIO · PI LOPEZ-RIBOT, JOSE L. · 2013 to 2017
$1.8M
Determination of morphology and virulence in Candida albicansR01AI083344 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI KADOSH, DAVID · 2010 to 2014
$1.8M
Development of Monoclonal Antibody (Mab) Biologics against Neonatal CandidiasisR03AI103295 · NIAID · UNIVERSITY OF TEXAS SAN ANTONIO · PI LOPEZ-RIBOT, JOSE L. · 2013 to 2014
$147k
NIAID NIH HHS R01 AI083344NIAID NIH HHS R01AI083344NIAID NIH HHS R03 AI103295NIAID NIH HHS R03AI103295NIDCR NIH HHS R01 DE023510NIDCR NIH HHS R01DE023510
6 · The paper itself

Abstract

In this issue of Cell Host & Microbe, Lu et al. (2013) report on the redundancy of signaling pathways controlling Candida albicans filamentation and pathogenicity. In the process, they provide important insight into how this normal commensal of humans adapts to different host microenvironments to become a highly successful opportunistic pathogen.

Indexed as

FoodGene Expression Regulation, FungalHypoxiaCandida albicansCarbon DioxideCarbon Dioxide

Identifiers

PMID24237692
PMCPMC3896085

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.